Predictive Oncology Balance Sheet Health
Financial Health criteria checks 6/6
Predictive Oncology has a total shareholder equity of $18.6M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $25.1M and $6.5M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$18.60m |
| Equity | US$18.55m |
| Total liabilities | US$6.51m |
| Total assets | US$25.06m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: S1K's short term assets ($19.8M) exceed its short term liabilities ($3.9M).
Long Term Liabilities: S1K's short term assets ($19.8M) exceed its long term liabilities ($2.6M).
Debt to Equity History and Analysis
Debt Level: S1K is debt free.
Reducing Debt: S1K had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: S1K has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: S1K has sufficient cash runway for 1.4 years if free cash flow continues to reduce at historical rates of 21.3% each year.